PNC Financial Services Group’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Other funds holding CTKB
PNC Financial Services Group's CTKB Position: Q3 2026 in Review
PNC Financial Services Group reduced its Cytek Biosciences (CTKB) stake by 29% in Q3 2026, selling an estimated $2.82K and leaving 1,427 shares worth $8.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4246.
PNC Financial Services Group first reported a position in CTKB in Q4 2021 and has held it in 20 quarters since. The position peaked at $82.5K in Q4 2025. 150 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.
- PNC Financial Services Group held 1,427 shares of Cytek Biosciences worth $8.5K as of Q3 2026.
- PNC Financial Services Group sold 595 Cytek Biosciences shares in Q3 2026, an estimated $2.82K.
- Cytek Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4246 holding.
- PNC Financial Services Group first reported a position in Cytek Biosciences in Q4 2021 and has held it in 20 quarters since.
- PNC Financial Services Group's Cytek Biosciences position peaked at $82.5K in Q4 2025.
- 150 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.